A more recent cross of BPH/2 with the apolipoprotein E-deficient mouse (APoE) was developed to examine the interaction between hypertension associated with high SNS activity with an atherosclerotic-prone mouse (Al-Sharea et al., 2019). This evidence concerns the gene APOE and benign prostatic hyperplasia.